Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

May 01, 1984; Volume 12,Issue 3
  • You have access
    Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo.
    M G Miller and D J Jollow
    Drug Metabolism and Disposition May 1984, 12 (3) 271-279;
  • You have access
    Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from laboratory animals.
    E H Pfadenhauer, C S Bankert, J Jensen, C E Jones, E E Jenkins and J A McCloskey
    Drug Metabolism and Disposition May 1984, 12 (3) 280-284;
  • You have access
    Effects of salicylate on maternal and fetal phenytoin pharmacokinetics in rats.
    P A Cleveland and C T Ueda
    Drug Metabolism and Disposition May 1984, 12 (3) 285-290;
  • You have access
    Multiple reactive metabolites derived from bromobenzene.
    S S Lau, T J Monks and J R Gillette
    Drug Metabolism and Disposition May 1984, 12 (3) 291-296;
  • You have access
    Synthesis and elimination reactions of methylsulfonium ions formed from styrene oxide and methylthio compounds related to methionine and cysteine.
    L S Sheng, E C Horning and M G Horning
    Drug Metabolism and Disposition May 1984, 12 (3) 297-303;
  • You have access
    Strain and sex differences in chloroform-induced nephrotoxicity. Different rates of metabolism of chloroform to phosgene by the mouse kidney.
    L R Pohl, J W George and H Satoh
    Drug Metabolism and Disposition May 1984, 12 (3) 304-308;
  • You have access
    Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.
    K S Pang, W F Cherry, J A Terrell and E H Ulm
    Drug Metabolism and Disposition May 1984, 12 (3) 309-313;
  • You have access
    Kinetics of procainamide N-acetylation in the rat in vivo and in the perfused rat liver preparation.
    K S Pang, J C Huang, C Finkle, P Kong, W F Cherry and S Fayz
    Drug Metabolism and Disposition May 1984, 12 (3) 314-322;
  • You have access
    Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation.
    S Fayz, W F Cherry, J R Dawson, G J Mulder and K S Pang
    Drug Metabolism and Disposition May 1984, 12 (3) 323-329;
  • You have access
    Biotransformation of gentian violet to leucogentian violet by human, rat, and chicken intestinal microflora.
    J J McDonald and C E Cerniglia
    Drug Metabolism and Disposition May 1984, 12 (3) 330-336;
  • You have access
    N-acetylcyanamide, the major urinary metabolite of cyanamide in rat, rabbit, dog, and man.
    F N Shirota, H T Nagasawa, C H Kwon and E G DeMaster
    Drug Metabolism and Disposition May 1984, 12 (3) 337-344;
  • You have access
    N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects.
    W L Nelson and M J Bartels
    Drug Metabolism and Disposition May 1984, 12 (3) 345-352;
  • You have access
    Rapid microbial degradation of organic nitrates in rat excreta. Re-examination of the urinary and fecal metabolite profiles of pentaerythritol tetranitrate in the rat.
    S Y King and H L Fung
    Drug Metabolism and Disposition May 1984, 12 (3) 353-357;
  • You have access
    Effects of cytochrome b5 on cytochrome P-450-catalyzed reactions. Studies with manganese-substituted cytochrome b5.
    E T Morgan and M J Coon
    Drug Metabolism and Disposition May 1984, 12 (3) 358-364;
  • You have access
    The disposition of the new anthracycline antibiotic, menogarol, in mice.
    P Dodion, B K Chang, M J Egorin, E A Olman, K L Engisch and N R Bachur
    Drug Metabolism and Disposition May 1984, 12 (3) 365-370;
  • You have access
    Metabolism-dependent inactivation of liver microsomal enzymes by phencyclidine.
    M K Hoag, A J Trevor, Y Asscher, J Weissman and N Castagnoli
    Drug Metabolism and Disposition May 1984, 12 (3) 371-375;
  • You have access
    Effect of Hg2+ on accumulation and metabolism of chlorpromazine and imipramine in rat lungs.
    Y Ohmiya and H M Mehendale
    Drug Metabolism and Disposition May 1984, 12 (3) 376-378;
  • You have access
    Characterization of age-related changes in hepatic drug metabolism in miniature swine.
    J O Peggins, L A Shipley and M Weiner
    Drug Metabolism and Disposition May 1984, 12 (3) 379-381;
  • You have access
    Stereoselectivity in the aromatic hydroxylation of propranolol in the rat: use of deuterium labeling and pseudoracemic mixtures.
    W L Nelson and M J Bartels
    Drug Metabolism and Disposition May 1984, 12 (3) 382-384;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 12, Issue 3
1 May 1984
  • Table of Contents
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics